{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:06:22Z","timestamp":1790143582535,"version":"4.0.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s40265-022-01696-1","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T17:03:08Z","timestamp":1649782988000},"page":"663-681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pharmacological Treatment for Pedophilic Disorder and Compulsive Sexual Behavior Disorder: A Review"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3249-8221","authenticated-orcid":false,"given":"Valdemar","family":"Landgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Savard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Dhejne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Jokinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Arver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1212-3388","authenticated-orcid":false,"given":"Michael C.","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8934-5130","authenticated-orcid":false,"given":"Christoffer","family":"Rahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"1696_CR1","doi-asserted-by":"publisher","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. American Psychiatric Association; 2013. https:\/\/doi.org\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"key":"1696_CR2","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1176\/appi.ajp.158.10.1590","volume":"158","author":"DJ Stein","year":"2001","unstructured":"Stein DJ, Black DW, Shapira NA, Spitzer RL. Hypersexual disorder and preoccupation with internet pornography. Am J Psychiatry. 2001;158:1590\u20134.","journal-title":"Am J Psychiatry"},{"key":"1696_CR3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1023\/A:1024507922470","volume":"26","author":"MP Kafka","year":"1997","unstructured":"Kafka MP. Hypersexual desire in males: an operational definition and clinical implications for males with paraphilias and paraphilia-related disorders. Arch Sex Behav. 1997;26:505\u201326.","journal-title":"Arch Sex Behav"},{"key":"1696_CR4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10508-009-9574-7","volume":"39","author":"MP Kafka","year":"2010","unstructured":"Kafka MP. Hypersexual disorder: a proposed diagnosis for DSM-V. Arch Sex Behav. 2010;39:377\u2013400.","journal-title":"Arch Sex Behav"},{"key":"1696_CR5","volume-title":"Out of the shadows: understanding sexual addiction","author":"P Carnes","year":"1983","unstructured":"Carnes P. Out of the shadows: understanding sexual addiction. San Francisco: CompCare Publications; 1983."},{"key":"1696_CR6","first-page":"189","volume-title":"Sexual compulsivity: Journal of Chemical Dependency Treatment","author":"E Coleman","year":"1987","unstructured":"Coleman E. Sexual compulsivity: Journal of Chemical Dependency Treatment. New York: Taylor & Francis; 1987. p. 189\u2013204."},{"key":"1696_CR7","unstructured":"World Health Organization. International Classification of Diseases 11th Revision. https:\/\/icd.who.int\/en. Accessed 2 Sept 2020."},{"key":"1696_CR8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eurpsy.2018.02.002","volume":"51","author":"H Gerwinn","year":"2018","unstructured":"Gerwinn H, Wei\u00df S, Tenbergen G, Amelung T, F\u00f6disch C, Pohl A, et al. Clinical characteristics associated with paedophilia and child sex offending\u2014differentiating sexual preference from offence status. Eur Psychiatry. 2018;51:74\u201385.","journal-title":"Eur Psychiatry"},{"key":"1696_CR9","doi-asserted-by":"crossref","first-page":"e0129730","DOI":"10.1371\/journal.pone.0129730","volume":"10","author":"V Klein","year":"2015","unstructured":"Klein V, Schmidt AF, Turner D, Briken P. Are sex drive and hypersexuality associated with pedophilic interest and cHild sexual abuse in a male community sample? PLoS\u00a0One. 2015;10:e0129730.","journal-title":"PLoS\u00a0One"},{"key":"1696_CR10","doi-asserted-by":"crossref","unstructured":"Landgren V, Malki K, Bottai M, Arver S, Rahm C. Effect of gonadotropin-releasing hormone antagonist on risk of committing child sexual abuse in men with Pedophilic disorder: a randomized clinical trial. JAMA Psychiatry. 2020;77(9):897\u2013905. https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2764552. Accessed 29 Apr 2020.","DOI":"10.1001\/jamapsychiatry.2020.0440"},{"key":"1696_CR11","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jsxm.2021.06.008","volume":"18","author":"R Adebahr","year":"2021","unstructured":"Adebahr R, S\u00f6derstr\u00f6m EZ, Arver S, Jokinen J, \u00d6berg KG. Reaching men and women at risk of committing sexual offences\u2014findings from the national Swedish telephone helpline PrevenTell. J Sex Med. 2021;18:1571\u201381.","journal-title":"J Sex Med"},{"key":"1696_CR12","doi-asserted-by":"crossref","first-page":"571775","DOI":"10.3389\/fpsyg.2020.571775","volume":"11","author":"F Wittstr\u00f6m","year":"2020","unstructured":"Wittstr\u00f6m F, L\u00e5ngstr\u00f6m N, Landgren V, Rahm C. Risk factors for sexual offending in self-referred men with pedophilic disorder: a Swedish case\u2013control study. Front Psychol. 2020;11:571775.","journal-title":"Front Psychol"},{"key":"1696_CR13","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1037\/0022-006X.73.6.1154","volume":"73","author":"RK Hanson","year":"2005","unstructured":"Hanson RK, Morton-Bourgon KE. The characteristics of persistent sexual offenders: a meta-analysis of recidivism studies. J Consult Clin Psychol. 2005;73:1154\u201363.","journal-title":"J Consult Clin Psychol"},{"key":"1696_CR14","doi-asserted-by":"crossref","unstructured":"Khan O, Ferriter M, Huband N, Powney MJ, Dennis JA, Duggan C. Pharmacological interventions for those who have sexually offended or are at risk of offending. Cochrane Database Syst Rev. 2015;18(2):CD007989.","DOI":"10.1002\/14651858.CD007989.pub2"},{"key":"1696_CR15","doi-asserted-by":"crossref","unstructured":"L\u00e5ngstr\u00f6m N, Enebrink P, Laur\u00e9n E-M, Lindblom J, Werk\u00f6 S, Hanson RK. Preventing sexual abusers of children from reoffending: systematic review of medical and psychological interventions. BMJ. 2013;347.","DOI":"10.1136\/bmj.f4630"},{"key":"1696_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.psc.2014.03.002","volume":"37","author":"AA Assump\u00e7\u00e3o","year":"2014","unstructured":"Assump\u00e7\u00e3o AA, Garcia FD, Garcia HD, Bradford JMW, Thibaut F. Pharmacologic treatment of paraphilias. Psychiatr Clin N Am. 2014;37:173\u201381.","journal-title":"Psychiatr Clin N Am"},{"key":"1696_CR17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/15622975.2020.1744723","volume":"21","author":"F Thibaut","year":"2020","unstructured":"Thibaut F, Cosyns P, Fedoroff JP, Briken P, Goethals K, Bradford JMW, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders. World J Biol Psychiatry. 2020;21:412\u201390.","journal-title":"World J Biol Psychiatry"},{"key":"1696_CR18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jsxm.2017.11.013","volume":"15","author":"D Turner","year":"2018","unstructured":"Turner D, Briken P. Treatment of paraphilic disorders in sexual offenders or men with a risk of sexual offending with luteinizing hormone-releasing hormone agonists: an updated systematic review. J Sex Med. 2018;15:77\u201393.","journal-title":"J Sex Med"},{"key":"1696_CR19","unstructured":"Troubled desire. Global Prevention Dunkelfeld. https:\/\/troubled-desire.com\/en\/. Accessed 23 Sept 2020."},{"key":"1696_CR20","unstructured":"About Us. Stop It Now. https:\/\/www.stopitnow.org\/about-us. Accessed 23 Sept 2020."},{"key":"1696_CR21","unstructured":"Preventell\u2014Help Line for Sex Addiction and Unwanted Sexuality. http:\/\/preventell.se\/?lang=en. Accessed 23 Sept 2020."},{"key":"1696_CR22","unstructured":"Don\u2019t Offend India. https:\/\/dontoffendindia.org\/. Accessed 23 Sept 2020."},{"issue":"3","key":"1696_CR23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1176\/appi.ajp.162.3.433","volume":"162","author":"KS Kendler","year":"2005","unstructured":"Kendler KS. Toward a philosophical structure for psychiatry. Am J Psychiatry. 2005;162(3):433\u201340.","journal-title":"Am J Psychiatry"},{"key":"1696_CR24","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1177\/0269881117714048","volume":"31","author":"A Lewis","year":"2017","unstructured":"Lewis A, Grubin D, Ross CC, Das M. Gonadotrophin-releasing hormone agonist treatment for sexual offenders: a systematic review. J Psychopharmacol. 2017;31:1281\u201393.","journal-title":"J Psychopharmacol"},{"key":"1696_CR25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/15622971003671628","volume":"11","author":"F Thibaut","year":"2010","unstructured":"Thibaut F, Barra FDL, Gordon H, Cosyns P, Bradford JM, WFSBP Task force on sexual disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of paraphilias. World J Biol Psychiatry. 2010;11:604\u201355.","journal-title":"World J Biol Psychiatry"},{"key":"1696_CR26","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"1696_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2021.2014683","author":"V Landgren","year":"2022","unstructured":"Landgren V, Olsson P, Briken P, Rahm C. Effects of testosterone suppression on desire, hypersexuality, and sexual interest in children in men with Pedophilic disorder. World J Biol Psychiatry. 2022. https:\/\/doi.org\/10.1080\/15622975.2021.2014683.","journal-title":"World J Biol Psychiatry"},{"key":"1696_CR28","unstructured":"Clinical Trials Register. https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2017-004984-11\/FR. Accessed 11 Jan 2021."},{"key":"1696_CR29","unstructured":"Clinical Trials Register. https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2016-002161-56\/PL. Accessed 11 Jan 2021."},{"key":"1696_CR30","unstructured":"Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale, France. Comparative Controlled Clinical Trial of Two Pharmacological Treatments of Pedophilia. ClinicalTrials.gov; 2009 Jul. Report No.: NCT00601276. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00601276."},{"key":"1696_CR31","unstructured":"University of Minnesota. A Double-Blind, Placebo-Controlled Study of Naltrexone in Compulsive Sexual Behavior. ClinicalTrials.gov; 2012 Apr. Report No.: NCT00467558. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00467558."},{"key":"1696_CR32","unstructured":"Clinical Trials Register. https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2018-001049-15\/SE. Accessed 6 Jan 2022."},{"key":"1696_CR33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1192\/bjp.125.3.310","volume":"125","author":"J Bancroft","year":"1974","unstructured":"Bancroft J, Tennent G, Loucas K, Cass J. The control of deviant sexual behaviour by drugs: I. Behavioural changes following oestrogens and anti-androgens. Br J Psychiatry. 1974;125:310\u20135.","journal-title":"Br J Psychiatry"},{"key":"1696_CR34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF01542555","volume":"22","author":"JMW Bradford","year":"1993","unstructured":"Bradford JMW, Pawlak A. Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias. Arch Sex Behav. 1993;22:383\u2013402.","journal-title":"Arch Sex Behav"},{"key":"1696_CR35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/070674379203701003","volume":"37","author":"AJ Cooper","year":"1992","unstructured":"Cooper AJ, Sandhu S, Losztyn S, Cernovsky Z. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles. Can J Psychiatry. 1992;37:687\u201393.","journal-title":"Can J Psychiatry"},{"key":"1696_CR36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0010-440X(81)90034-1","volume":"22","author":"AJ Cooper","year":"1981","unstructured":"Cooper AJ. A placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality. Compr Psychiatry. 1981;22:458\u201365.","journal-title":"Compr Psychiatry"},{"issue":"2","key":"1696_CR37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00852799","volume":"1","author":"S Hucker","year":"1988","unstructured":"Hucker S, Langevin R, Bain J. A double blind trial of sex drive reducing medication in pedophiles. Ann Sex Res. 1988;1(2):227\u201342.","journal-title":"Ann Sex Res"},{"key":"1696_CR38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF01542257","volume":"21","author":"MJP Kruesi","year":"1992","unstructured":"Kruesi MJP, Fine S, Valladares L, Phillips RA, Rapoport JL. Paraphilias: a double-blind crossover comparison of clomipramine versus desipramine. Arch Sex Behav. 1992;21:587\u201393.","journal-title":"Arch Sex Behav"},{"key":"1696_CR39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-0447.1988.tb05101.x","volume":"77","author":"N McConaghy","year":"1988","unstructured":"McConaghy N, Blaszczynski A, Kidson W. Treatment of sex offenders with imaginal desensitization and\/or medroxyprogesterone. Acta Psychiatr Scand. 1988;77:199\u2013206.","journal-title":"Acta Psychiatr Scand"},{"key":"1696_CR40","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10508-005-7929-2","volume":"34","author":"JM Schober","year":"2005","unstructured":"Schober JM, Kuhn PJ, Kovacs PG, Earle JH, Byrne PM, Fries RA. Leuprolide acetate suppresses pedophilic urges and arousability. Arch Sex Behav. 2005;34:691\u2013705.","journal-title":"Arch Sex Behav"},{"key":"1696_CR41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF01541489","volume":"3","author":"G Tennent","year":"1974","unstructured":"Tennent G, Bancroft J, Cass J. The control of deviant sexual behavior by drugs: a double-blind controlled study of benperidol, chlorpromazine, and placebo. Arch Sex Behav. 1974;3:261\u201371.","journal-title":"Arch Sex Behav"},{"issue":"12","key":"1696_CR42","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.4088\/JCP.v67n1218","volume":"67","author":"JP Wainberg","year":"2006","unstructured":"Wainberg JP, et al. A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. J Clin Psychiatry. 2006;67(12):1968\u201373.","journal-title":"J Clin Psychiatry"},{"key":"1696_CR43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF01550364","volume":"15","author":"JP Wincze","year":"1986","unstructured":"Wincze JP, Bansal S, Malamud M. Effects of medroxyprogesterone acetate on subjective arousal, arousal to erotic stimulation, and nocturnal penile tumescence in male sex offenders. Arch Sex Behav. 1986;15:293\u2013305.","journal-title":"Arch Sex Behav"},{"key":"1696_CR44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/jcem-73-3-621","volume":"73","author":"JS Finkelstein","year":"1991","unstructured":"Finkelstein JS, O\u2019Dea LS, Whitcomb RW, Crowley WF. Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab. 1991;73:621\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1696_CR45","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1210\/jcem-59-5-963","volume":"59","author":"UA Knuth","year":"1984","unstructured":"Knuth UA, Hano R, Nieschlag E. Effect of flutamide or cyproterone acetate on pituitary and testicular hormones in normal men. J Clin Endocrinol Metab. 1984;59:963\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1696_CR46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/pros.2990240403","volume":"24","author":"N Warriar","year":"1994","unstructured":"Warriar N, Pag\u00e9 N, Koutsilieris M, Govindan MV. Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP. Prostate. 1994;24:176\u201386.","journal-title":"Prostate"},{"key":"1696_CR47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1756287211414457","volume":"3","author":"L Boccon-Gibod","year":"2011","unstructured":"Boccon-Gibod L, van der Meulen E, Persson B-E. An update on the use of gonadotropin-releasing hormone antagonists in prostate cancer. Ther Adv Urol. 2011;3:127\u201340.","journal-title":"Ther Adv Urol"},{"key":"1696_CR48","volume-title":"Stahl\u2019s essential psychopharmacology: neuroscientific basis and practical applications","author":"SM Stahl","year":"2013","unstructured":"Stahl SM. Stahl\u2019s essential psychopharmacology: neuroscientific basis and practical applications. Cambridge: Cambridge University Press; 2013."},{"key":"1696_CR49","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1743-6109.2009.01309.x","volume":"6","author":"JG Pfaus","year":"2009","unstructured":"Pfaus JG. Pathways of sexual desire. J Sex Med. 2009;6:1506\u201333.","journal-title":"J Sex Med"},{"key":"1696_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010631.pub2\/full","volume-title":"Chlorpromazine versus atypical antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews","author":"KB Saha","year":"2016","unstructured":"Saha KB, Bo L, Zhao S, Xia J, Sampson S, Zaman RU. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews. New York: Wiley; 2016. https:\/\/doi.org\/10.1002\/14651858.CD010631.pub2\/full."},{"key":"1696_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003083.pub2\/full","volume-title":"Benperidol for schizophrenia. Cochrane database of systematic reviews","author":"C Schwarz","year":"2005","unstructured":"Schwarz C, Hartung B, Leucht S. Benperidol for schizophrenia. Cochrane database of systematic reviews. New York: Wiley; 2005. https:\/\/doi.org\/10.1002\/14651858.CD003083.pub2\/full."},{"key":"1696_CR52","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3389\/fpsyt.2019.00940","volume":"10","author":"K Jordan","year":"2019","unstructured":"Jordan K, Wild TSN, Fromberger P, M\u00fcller I, M\u00fcller JL. Are there any biomarkers for Pedophilia and sexual child abuse? A Review. Front Psychiatry. 2019;10:940.","journal-title":"Front Psychiatry"},{"key":"1696_CR53","doi-asserted-by":"crossref","first-page":"R297","DOI":"10.1530\/ERC-17-0153","volume":"24","author":"N Russell","year":"2017","unstructured":"Russell N, Cheung A, Grossmann M. Estradiol for the mitigation of adverse effects of androgen deprivation therapy. Endocr Relat Cancer. 2017;24:R297-313.","journal-title":"Endocr Relat Cancer"},{"key":"1696_CR54","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1206168","volume":"369","author":"JS Finkelstein","year":"2013","unstructured":"Finkelstein JS, Lee H, Burnett-Bowie S-AM, Pallais JC, Yu EW, Borges LF, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013;369:1011\u201322.","journal-title":"N Engl J Med"},{"key":"1696_CR55","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1172\/JCI84137","volume":"126","author":"JS Finkelstein","year":"2016","unstructured":"Finkelstein JS, Lee H, Leder BZ, Burnett-Bowie S-AM, Goldstein DW, Hahn CW, et al. Gonadal steroid\u2013dependent effects on bone turnover and bone mineral density in men. J Clin Investig. 2016;126:1114\u201325.","journal-title":"J Clin Investig"},{"key":"1696_CR56","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1210\/jc.2016-1612","volume":"101","author":"AP Taylor","year":"2016","unstructured":"Taylor AP, Lee H, Webb ML, Joffe H, Finkelstein JS. Effects of testosterone and estradiol deficiency on vasomotor symptoms in hypogonadal men. J Clin Endocrinol Metab. 2016;101:3479\u201386.","journal-title":"J Clin Endocrinol Metab"},{"key":"1696_CR57","unstructured":"Dimitrova EK. Restrictions in use of cyproterone due to meningioma risk. European Medicines Agency. 2020. https:\/\/www.ema.europa.eu\/en\/news\/restrictions-use-cyproterone-due-meningioma-risk. Accessed 2 Sept 2020."},{"key":"1696_CR58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4088\/PCC.v03n0105","volume":"3","author":"JM Ferguson","year":"2001","unstructured":"Ferguson JM. SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clin Psychiatry. 2001;3:22\u20137.","journal-title":"Prim Care Companion J Clin Psychiatry."},{"key":"1696_CR59","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","volume":"340","author":"D Moher","year":"2010","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869\u2013c869.","journal-title":"BMJ"},{"key":"1696_CR60","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJMsb1901642","volume":"382","author":"R Collins","year":"2020","unstructured":"Collins R, Bowman L, Landray M, Peto R. The magic of randomization versus the myth of real-world evidence. N Engl J Med. 2020;382:674\u20138.","journal-title":"N Engl J Med"},{"key":"1696_CR61","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jclinepi.2018.02.022","volume":"101","author":"W Zhao","year":"2018","unstructured":"Zhao W, Berger V. Imbalance control in clinical trial subject randomization\u2014from philosophy to strategy. J Clin Epidemiol. 2018;101:116\u20138.","journal-title":"J Clin Epidemiol"},{"key":"1696_CR62","unstructured":"Catalogue of Bias. Catalog of Bias. 2017. https:\/\/catalogofbias.org\/. Accessed 2 Sep 2020."},{"key":"1696_CR63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/107906320701900207","volume":"19","author":"WL Marshall","year":"2007","unstructured":"Marshall WL, Marshall LE. The utility of the random controlled trial for evaluating sexual offender treatment: the gold standard or an inappropriate strategy? Sex Abuse. 2007;19:175\u201391.","journal-title":"Sex Abuse"},{"key":"1696_CR64","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1079063208317733","volume":"20","author":"MC Seto","year":"2008","unstructured":"Seto MC, Marques JK, Harris GT, Chaffin M, Lalumi\u00e8re ML, Miner MH, et al. Good science and progress in sex offender treatment are intertwined: a response to Marshall and Marshall (2007). Sex Abuse. 2008;20:247\u201355.","journal-title":"Sex Abuse"},{"key":"1696_CR65","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1001\/jama.2012.13444","volume":"308","author":"TV Pereira","year":"2012","unstructured":"Pereira TV, Horwitz RI, Ioannidis JPA. Empirical evaluation of very large treatment effects of medical interventions. JAMA. 2012;308:1676\u201384.","journal-title":"JAMA"},{"key":"1696_CR66","doi-asserted-by":"crossref","first-page":"e45183","DOI":"10.7554\/eLife.45183","volume":"8","author":"D Herrera-Perez","year":"2019","unstructured":"Herrera-Perez D, Haslam A, Crain T, Gill J, Livingston C, Kaestner V, et al. A comprehensive review of randomized clinical trials in three medical journals reveals 396 medical reversals. Elife. 2019;8:e45183.","journal-title":"Elife"},{"key":"1696_CR67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jclinepi.2020.12.012","volume":"132","author":"I Michopoulos","year":"2021","unstructured":"Michopoulos I, Furukawa TA, Noma H, Kishimoto S, Onishi A, Ostinelli EG, et al. Different control conditions can produce different effect estimates in psychotherapy trials for depression. J Clin Epidemiol. 2021;132:59\u201370.","journal-title":"J Clin Epidemiol"},{"key":"1696_CR68","unstructured":"ISRCTN Registry. ISRCTN76841676: Prevent it: Can internet-delivered psychotherapy reduce usage of online child sexual abuse material? https:\/\/www.isrctn.com\/ISRCTN76841676. Accessed 15 Sept 2021."},{"issue":"3","key":"1696_CR69","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1556\/2006.2021.00044","volume":"10","author":"J Savard","year":"2021","unstructured":"Savard J, Hirvikoski T, \u00d6berg KG, Dhejne C, Rahm C, Jokinen J. Impulsivity in compulsive sexual behavior disorder and pedophilic disorder. J Behav Addict. 2021;10(3):839\u201347.","journal-title":"J Behav Addict"},{"key":"1696_CR70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1079063217720919","volume":"31","author":"MC Seto","year":"2019","unstructured":"Seto MC. The motivation-facilitation model of sexual offending. Sex Abuse. 2019;31:3\u201324.","journal-title":"Sex Abuse"},{"key":"1696_CR71","volume-title":"Pedophilia and sexual offending against children: theory, assessment, and intervention","author":"MC Seto","year":"2018","unstructured":"Seto MC. Pedophilia and sexual offending against children: theory, assessment, and intervention. 2nd ed. Washington, DC: American Psychological Association; 2018.","edition":"2"},{"key":"1696_CR72","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0197-2456(00)00046-5","volume":"21","author":"JM Lachin","year":"2000","unstructured":"Lachin JM. Statistical considerations in the intent-to-treat principle. Control Clin Trials. 2000;21:167\u201389.","journal-title":"Control Clin Trials"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-022-01696-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-022-01696-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-022-01696-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T23:26:45Z","timestamp":1651620405000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-022-01696-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1696"],"URL":"https:\/\/doi.org\/10.1007\/s40265-022-01696-1","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"2 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Karolinska Institute.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Valdemar Landgren, Josephine Savard, Cecilia Dhejne, Stefan Arver, Michael C. Seto, and Christoffer Rahm report no conflicts of interest. JJ has participated in Advisory Boards for Janssen regarding esketamine for MDD with current suicidal ideation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JS, VL, and CR conceived and designed the analysis. JS and VL performed the literature search. JS, VL and CR undertook the revisions. JS, VL, MS, CD, SA, JJ, and CR wrote the paper, approved the final version of the manuscript for submission, and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}